Immunotherapies and COVID-19 mortality: a multidisciplinary open data analysis based on FDA's Adverse Event Reporting System
M Pistor, AGF Hoepner, Y Lin, S Jung… - Annals of the …, 2021 - ard.bmj.com
… As reference groups (Region, Immunotherapy, Month), we … with a higher COVID-19 mortality
risk in people with autoimmune … sex as relevant predictors of COVID-19-associated mortality, …
risk in people with autoimmune … sex as relevant predictors of COVID-19-associated mortality, …
mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non …
SF Oosting, AAM van der Veldt… - The Lancet …, 2021 - thelancet.com
… and safety of COVID-19 vaccines for patients with solid … Therefore, we aimed to assess the
impact of immunotherapy, … ) COVID-19 vaccine as part of the Vaccination Against COVID in …
impact of immunotherapy, … ) COVID-19 vaccine as part of the Vaccination Against COVID in …
Potential protective and therapeutic role of immune checkpoint inhibitors against viral infections and COVID-19
L Gatto, E Franceschi, VD Nunno, AA Brandes - Immunotherapy, 2020 - Taylor & Francis
… dramatically expanded, becoming an effective treatment option for a wide variety of cancers,
… serious pneumonia in case of COVID-19 [Citation3]. Human COVID-19 presents with a wide …
… serious pneumonia in case of COVID-19 [Citation3]. Human COVID-19 presents with a wide …
[HTML][HTML] Immunotherapy for ANCA-associated vasculitis during the COVID-19 pandemic
EJ Gapud, A Kronbichler, P Gauckler… - European Journal of …, 2020 - ncbi.nlm.nih.gov
… patients including those with autoimmune diseases may be at increased risk for developing
Coronavirus Disease 2019 (COVID-19) … and disease course of COVID-19. In this review, we …
Coronavirus Disease 2019 (COVID-19) … and disease course of COVID-19. In this review, we …
Challenges of cancer immunotherapy during the COVID-19 pandemic
NM Kuderer, GH Lyman - Cancer Investigation, 2021 - Taylor & Francis
… impact of immunotherapy on the risk of COVID-19 and its … symptoms of COVID-19 from
irAEs in patients receiving ICIs and … of patients presenting with COVID-19 (Citation18,Citation19). …
irAEs in patients receiving ICIs and … of patients presenting with COVID-19 (Citation18,Citation19). …
Patients with hematological malignancies treated with T-cell or B-cell immunotherapy remain at high risk of severe forms of COVID-19 in the omicron era
J Zerbit, M Detroit, A Meyer, J Decroocq… - Viruses, 2022 - mdpi.com
… Moreover, anti-SARS-CoV-2 mAbs became potential options for COVID-19 immunoprophylaxis
from August 2021. The casirivimab/imdevimab combination was first used for pre-…
from August 2021. The casirivimab/imdevimab combination was first used for pre-…
Host-directed immunotherapy of viral and bacterial infections: past, present and future
… to assist in the selection of appropriate immunotherapies for specific patients. The role of
specific … Improved immunotherapies for COVID-19 will depend on a better understanding of the …
specific … Improved immunotherapies for COVID-19 will depend on a better understanding of the …
Passive Immunotherapeutic Approaches for Treating Covid-19: A Comprehensive Review
R Aadhith, PB Devi - … Journal of Pharmaceutical Research and Allied …, 2022 - ijpras.com
… patient [31]. Numerous methodologies can be directed as immunotherapeutic medicines
for COVID‐19. … , we conclude that immunotherapy is an effective treatment against COVID-19. …
for COVID‐19. … , we conclude that immunotherapy is an effective treatment against COVID-19. …
Impact of immunotherapies on COVID-19 outcomes in multiple sclerosis patients
C Zanetta, MA Rocca, M Filippi - Expert Review of Clinical …, 2022 - Taylor & Francis
… and disease severity in patients with multiple sclerosis (pwMS). We analyze the impact of
immunotherapies on COVID-19 outcomes in pwMS, providing our interpretation of data. …
immunotherapies on COVID-19 outcomes in pwMS, providing our interpretation of data. …
Targeted therapy in Coronavirus disease 2019 (COVID-19): Implication from cell and gene therapy to immunotherapy and vaccine
M Shirzad, M Nourigorji, A Sajedi, M Ranjbar… - International …, 2022 - Elsevier
… therapeutic option has not been approved for COVID-19 and a variety … COVID-19. The aim
of this article is to describe the treatment strategies that have been used for COVID-19 patients …
of this article is to describe the treatment strategies that have been used for COVID-19 patients …